{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:00:12Z","timestamp":1774353612791,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","award":["11-10-R87-B-A3628-22687"],"award-info":[{"award-number":["11-10-R87-B-A3628-22687"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.atherosclerosis.2018.06.864","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T22:41:11Z","timestamp":1529448071000},"page":"319-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease"],"prefix":"10.1016","volume":"275","author":[{"given":"Jakob","family":"Schroder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke","family":"Zethner-Moller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira Bang","family":"Bov\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naja Dam","family":"Mygind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Hasbak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Mide","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.06.864_bib1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"No obstructive coronary artery disease (INOCA)","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2018.06.864_bib2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2009.425","article-title":"Persistent chest pain and No obstructive coronary artery disease","volume":"301","author":"Phan","year":"2009","journal-title":"J.\u00a0Am. Med. Assoc."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2018.06.864_bib3","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.864_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","article-title":"Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease","volume":"24","author":"Tona","year":"2014","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2016.08.026","article-title":"Circulating progenitor cells and coronary microvascular dysfunction: results from the NHLBI-sponsored Women's ischemia syndrome evaluation \u2013 coronary vascular dysfunction study (WISE-CVD)","volume":"253","author":"Mekonnen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.06.864_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jcmg.2012.12.011","article-title":"Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease","volume":"6","author":"Recio-Mayoral","year":"2013","journal-title":"JACC Cardiovasc Imag"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.864_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2014.09.014","article-title":"Serum concentrations of galectin-3 in patients with cardiac syndrome X","volume":"237","author":"Bozcali","year":"2014","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.864_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2014.12.025","article-title":"Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease","volume":"239","author":"Mekonnen","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.864_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1253\/circj.CJ-11-0959","article-title":"Coronary slow flow - prevalence and clinical correlations","volume":"76","author":"Hawkins","year":"2012","journal-title":"Circ. J."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2018.06.864_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.864_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ahj.2014.01.003","article-title":"Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale","volume":"167","author":"Prescott","year":"2014","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.06.864_bib12","article-title":"Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and No obstructive coronary artery disease: the iPOWER study","volume":"5","author":"Mygind","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijcard.2016.11.004","article-title":"Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: the iPOWER study","volume":"228","author":"Michelsen","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.06.864_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0163-7258(90)90060-F","article-title":"Cyclic AMP and mechanisms of vasodilation","volume":"47","author":"Murray","year":"1990","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.06.864_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-3565(25)20277-4","article-title":"Inhibition of adenylate cyclase attenuates adenosine receptor-mediated relaxation in coronary artery","volume":"259","author":"Sabouni","year":"1991","journal-title":"J.\u00a0Pharmacol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.06.864_bib16","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00259-007-0478-2","article-title":"Quantification of myocardial blood flow with 82Rb dynamic PET imaging","volume":"34","author":"Lortie","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.864_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-Plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib18","unstructured":"Corre J, H\u00e9braud B, Bourin P. Concise Review: growth Differentiation Factor 15 in Pathology: A Clinical Role?"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib19","first-page":"11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u2424 superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.carpath.2012.02.003","article-title":"Increased expression of the TGF-b superfamily cytokine MIC-1\/GDF15 protects ApoE\u00a0\u2212\/\u2212 mice from the development of atherosclerosis","volume":"21","author":"Johnen","year":"2012","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib21","unstructured":"Bonaterra GA, Z\u20ac Ugel S, Thogersen J, Walter SA, Haberkorn U, Strelau J, et\u00a0al. Growth Differentiation Factor-15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin-6\u2013dependent Inflammatory Response to Vascular Injury."},{"issue":"12319","key":"10.1016\/j.atherosclerosis.2018.06.864_bib22","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1161\/CIRCULATIONAHA.110.979740","article-title":"Growth-differentiation Factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo study","volume":"17","author":"Daniels","year":"2011","journal-title":"Circ"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.06.864_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality","volume":"9","author":"Wiklund","year":"2010","journal-title":"Aging Cell"},{"issue":"9324","key":"10.1016\/j.atherosclerosis.2018.06.864_bib24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(02)09093-1","article-title":"Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study","volume":"359","author":"Brown","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.864_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1373\/clinchem.2016.260570","article-title":"Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease","volume":"63","author":"Hagstr\u00f6m","year":"2017","journal-title":"Clin. Chem."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2018.06.864_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehv491","article-title":"Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study","volume":"37","author":"Hagstr\u00f6m","year":"2016","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.864_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.864_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.21.4.611","article-title":"Prospective study of fibrinolytic factors and incident coronary heart Disease\u202f: the atherosclerosis risk in communities (ARIC) study","volume":"21","author":"Folsom","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib29","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1538-7836.2006.01979.x","article-title":"Plasminogen and plasmin activity in patients with coronary artery disease","volume":"4","author":"Drinane","year":"2006","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.722827","article-title":"Von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes von Willebrand factor in cardiovascular disease focus on acute coronary syndromes","volume":"117","author":"Spiel","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.06.864_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2796.2000.00715.x","article-title":"Markers of hypercoagulation and von Willebrand factor in postmenopausal women with unstable coronary artery disease. Discriminatory ability regarding unstable coronary artery disease and coronary atherosclerosis using receiver operating characteristics","volume":"248","author":"Nielsen","year":"2000","journal-title":"J.\u00a0Intern. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.06.864_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1160\/TH14-07-0589","article-title":"Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study","volume":"113","author":"Sonneveld","year":"2015","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/hrt.80.4.334","article-title":"Von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction","volume":"80","author":"Jansson","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib34","unstructured":"Muller O, Bartunek J, Hamilos M, Trana Berza C, Mangiacapra F, Ntalianis A, et\u00a0al. von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina."},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib35","first-page":"345","volume":"172","author":"Anderson","year":"2004"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/B:GLYC.0000025819.54723.a0","article-title":"Galectin-4 in normal tissues and cancer Introduction: early discoveries, basic properties, and expression in normal tissues","volume":"20","author":"Huflejt","year":"2004","journal-title":"Glycoconj. J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.864_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13402-012-0109-1","article-title":"Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients","volume":"36","author":"Barrow","year":"2013","journal-title":"Cell. Oncol."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2018.06.864_bib38","first-page":"7035","article-title":"Serum Galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular","volume":"1","author":"Barrow","year":"2011","journal-title":"Endothelium"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib39","series-title":"Circulating Galectins -2, -4 and -8 in Cancer Patients Make Important Contributions to the Increased Circulation of Several Cytokines and Chemokines that Promote Angiogenesis and Metastasis","first-page":"741","author":"Chen","year":"2014"},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib40","series-title":"During Myocardial Ischemia\/Reperfusion","author":"Receptor","year":"2015"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.864_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-Reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.864_bib42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.06.864_bib43","doi-asserted-by":"crossref","first-page":"48B","DOI":"10.1016\/j.amjcard.2015.01.041","article-title":"ST2 in stable and unstable ischemic heart diseases","volume":"115","author":"Richards","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.06.864_bib44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1373\/clinchem.2013.209858","article-title":"Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the ludwigshafen risk and cardiovascular health study","volume":"60","author":"Dieplinger","year":"2014","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2018.06.864_bib45","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/STROKEAHA.115.009026","article-title":"Associations of circulating growth differentiation Factor-15 and ST2 concentrations with subclinical vascular brain injury and incident stroke","volume":"46","author":"Andersson","year":"2015","journal-title":"Stroke"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2018.06.864_bib46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.864_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcmg.2011.02.008","article-title":"Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers","volume":"4","author":"Sdringola","year":"2011","journal-title":"JACC Cardiovasc Imag"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.864_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2967\/jnumed.108.055673","article-title":"Repeatability of rest and hyperemic myocardial blood flow measurements with 82Rb dynamic PET","volume":"50","author":"Manabe","year":"2008","journal-title":"J.\u00a0Nucl. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.06.864_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur. J. Echocardiogr."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018311766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018311766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T06:21:23Z","timestamp":1751696483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018311766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":49,"alternative-id":["S0021915018311766"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.864","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}